Phosphodiesterase Type 5 Inhibition with Tadalafil Changes Outcomes in Heart Failure (PITCH-HF) (2015)
; 2017: Interventional, Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, NCT01910389